CALLAVID Trademark

Trademark Overview


On Friday, February 9, 2024, a trademark application was filed for CALLAVID with the United States Patent and Trademark Office. The USPTO has given the CALLAVID trademark a serial number of 79401819. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, November 13, 2025. This trademark is owned by Calla Lily Clinical Care Ltd. The CALLAVID trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical and medical preparations for use in the area of the vagina; sanitary preparations for medical purposes; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceutical preparations including probiotics for medicinal use; drug delivery agents being compounds for use in the vagina that facilitate the delivery of pharmaceutical preparations including probiotics for medicinal use; absorbent sanitary articles being sanitary pads, tampons or a combination of the two; novel cancer therapies, namely, pharmaceutical preparations and substances for the treatment of cancer; moisturisers, gels, creams and pessaries for use within and in the area of the vagina, all for medical purposes

Medical apparatus and instruments for use in gynecological medicine; intra-vaginal apparatus for administering lubricants, moisturisers, gels, creams and vaginal suppositories; intra-vaginal pessaries being vaginal drug delivery devices for administering medications and therapeutics; intra-vaginal pessaries being vaginal drug delivery devices for use in pregnancy loss and prevention; intra-vaginal pessaries being vaginal drug delivery devices for use in IVF; intra-vaginal pessaries being vaginal drug delivery devices for use in menopause; intra-vaginal pessaries being vaginal drug delivery devices for the treatment of cancer; intra-vaginal pessaries being vaginal delivery devices for use in delivering probiotic preparations; intra-vaginal pessaries being vaginal drug delivery devices for use in treating vaginal symptoms; intra-vaginal pessaries being vaginal delivery devices for use in delivering pharmaceutical preparations for use in artificial insemination; intra-vaginal pessaries be...
callavid

General Information


Serial Number79401819
Word MarkCALLAVID
Filing DateFriday, February 9, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, November 13, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 2, 2025

Trademark Statements


Goods and ServicesPharmaceutical and medical preparations for use in the area of the vagina; sanitary preparations for medical purposes; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceutical preparations including probiotics for medicinal use; drug delivery agents being compounds for use in the vagina that facilitate the delivery of pharmaceutical preparations including probiotics for medicinal use; absorbent sanitary articles being sanitary pads, tampons or a combination of the two; novel cancer therapies, namely, pharmaceutical preparations and substances for the treatment of cancer; moisturisers, gels, creams and pessaries for use within and in the area of the vagina, all for medical purposes
Goods and ServicesMedical apparatus and instruments for use in gynecological medicine; intra-vaginal apparatus for administering lubricants, moisturisers, gels, creams and vaginal suppositories; intra-vaginal pessaries being vaginal drug delivery devices for administering medications and therapeutics; intra-vaginal pessaries being vaginal drug delivery devices for use in pregnancy loss and prevention; intra-vaginal pessaries being vaginal drug delivery devices for use in IVF; intra-vaginal pessaries being vaginal drug delivery devices for use in menopause; intra-vaginal pessaries being vaginal drug delivery devices for the treatment of cancer; intra-vaginal pessaries being vaginal delivery devices for use in delivering probiotic preparations; intra-vaginal pessaries being vaginal drug delivery devices for use in treating vaginal symptoms; intra-vaginal pessaries being vaginal delivery devices for use in delivering pharmaceutical preparations for use in artificial insemination; intra-vaginal pessaries being vaginal drug delivery devices for administering drugs internally; replacement parts and structural fittings for all the aforesaid goods
Pseudo MarkCALL AVID

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 8, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, August 8, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCalla Lily Clinical Care Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Thursday, August 8, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, August 19, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 19, 2024APPLICATION FILING RECEIPT MAILED
Tuesday, September 3, 2024ASSIGNED TO EXAMINER
Tuesday, September 10, 2024NON-FINAL ACTION WRITTEN
Wednesday, September 11, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, September 13, 2024REFUSAL PROCESSED BY MPU
Friday, September 13, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, October 8, 2024REFUSAL PROCESSED BY IB
Thursday, March 13, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 13, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 13, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 16, 2025FINAL REFUSAL WRITTEN
Wednesday, April 16, 2025FINAL REFUSAL E-MAILED
Wednesday, April 16, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, September 22, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 22, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 22, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 13, 2025TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, October 13, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 13, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 5, 2025APPROVED FOR PUB - PRINCIPAL REGISTER